Cancer

Cancer refers to a group of more than a hundred diseases that can originate in many different parts of the body. Cancer begins in your cells, which are the building blocks of your body.

Metabolic Flexibility in Cancer: How Diet and Nutrition Shape Tumor Survival and Resistance

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, microenvironmental stress, and therapeutic pressure. This article explains how dietary interventions may exploit metabolic flexibility and plasticity to enhance treatment response while accounting for tumor heterogeneity.

Using Biomarkers to Detect Cancer

What Causes Cancer?

Cancer Pathophysiology

Discovery of Blood Cancer Cells that show Plasma Cell-Like Differentiation

What is Immunochemotherapy?

TARDIS: The Improved Method of Detecting Breast Cancer

Cancer Prevention: Lowering your Risk

Cancer Pain

CDK9 and Cancer

Insights into Oncofertility

Proto-Oncogene Activation: The Genetic Shift that Fuels Cancer

See more featured articles »

Metastatic Migration in Cancer may be Influenced by Metabolism

Cured Meats, Nitrates, and Cancer Risk: Why Food Source and Processing Matter

Transforming Cancer Care through Genomic Testing

Insight into Cancer Vaccines

Exploiting Enzymes in Cancer Diagnosis and Therapy

Cancer Prognosis

The Biochemistry of Breast Cancer Screening

The Effects of Cancer on Family Life

Cancer Glossary

Secondary Brain Cancer

Cancer Screening Considerations: Balancing the Benefits and Risks

Tyrosine Kinase Inhibitors for Targeted Cancer Therapy

British Pioneers in Cancer Biology

Cancer Classification

Living with Cancer Pain

What Role do Biobanks Play in Cancer Research?

Cancer Research

Cancer Management

Cancer Plasticity: The Shape-Shifting Threat Challenging Modern Treatments

Cutaneous Manifestations of Internal Malignancy

Microfluidic cancer treatment screen combined with flow cytometry

The Cancer Cell Surface Proteome as a Therapeutic Target

Pediatric Cancer

Is Cancer a Metabolic Disorder?

What is Merkel Cell Carcinoma?

Investigating the Molecular Mechanisms of Cancer

What is Cancer of Unknown Primary?

Targeted Cancer Therapies

Cancer Diagnosis

Assay for Monitoring and Treating Malignant Brain Tumors

Effects of Social and Economic Deprivation on Cancer Mortality

Overview of Cell Viability and Cytotoxicity

Secondary Lung Cancer

Cancer Symptoms

Cancer History

Myc Mutations and Cancer

Why are Cancer Cell Lines Useful?

Acidosis and Tumor Progression

How Camomile Could Prevent Neutropenia in Pediatric Leukemia Patients

What is the Tumor Microenvironment?

What is Tumorigenesis?

Hot vs Cold: the differences between tumor types

Nanostructured toxins for the selective destruction of drug-resistant human CXCR4style+ colorectal cancer stem cells

Extracellular Vesicles as Floating Cancer Biomarkers

Cancer Pain Management

Caring for a Loved One with Cancer

How Immune Checkpoint Inhibitors have Revolutionized Cancer Treatment

Hypoxia Markers and Their Importance

What is Cancer?

Cancer Epidemiology

Latest Cancer News and Research

New economic tool helps planners consider urban public health impacts

Senior urban development decision-makers have revealed there is currently little incentive to consider public health impacts when shaping towns and cities, according to a new study that highlights the potential of an innovative economic valuation tool to address the problem.

10 Sep 2026

Review highlights solute carriers as targets for central nervous system disorders

Solute carriers (SLCs) are specialized transport proteins that control the movement of nutrients, ions and neurotransmitters across cell membranes and are essential for brain metabolism and neuronal communication.

10 Sep 2026

New treatment approach preserves organs, improves survival in head and neck cancer patients

Patients with locally advanced head and neck squamous cell carcinoma (HNSCC) whose tumors responded to neoadjuvant immunochemotherapy (ICT) and who underwent less extensive surgery had high disease-free survival and organ preservation rates.

10 Sep 2026

New AI tool predicts breast cancer risk using repeated 3D mammograms

An artificial intelligence model that analyzes women's past and recent annual 3D mammograms is more effective at predicting five-year risk of developing breast cancer than a tool that uses only the most recent, single 3D mammogram, as well as an AI model that analyzes 2D mammograms, a new study shows.

10 Sep 2026

Yourgene Health launches Insight DPYD assay (IVDR)

Yourgene Health (part of the Novacyt Group), an international molecular diagnostics company with a broad portfolio of integrated technologies and services, announces the commercial launch of its In Vitro Diagnostic Regulation (IVDR)-certified Yourgene® Insight DPYD assay, expanding the Company's clinical genetics portfolio across regulated European markets.

From Yourgene Health 9 Sep 2026

Chaotic tumor environments may trigger cancer cell invasion

In 2024, malignant tumors caused more than 21,300 deaths in Austria, 4.7% more than in 2014. Faced with a similarly pressing global challenge, scientists are striving to better understand what drives cancer cells to grow, spread, and invade healthy tissue.

9 Sep 2026

Study reveals processes driving DNA damage in prostate cancer

Cancer begins with errors in the DNA inside our cells, and those errors are often more complicated than a handful of mutated genes.

9 Sep 2026

Protein-based MRI agent detects tiny lung cancer metastases

A multi-institutional research team led by Georgia State University Regents' Professor Emerita of Biochemistry and Biophysical Chemistry Jenny J. Yang has developed a new class of protein-based MRI contrast agent that detects invasive lung cancer and metastatic disease at earlier stages than conventional imaging approaches.

9 Sep 2026

Study links methylglyoxal stress to immunotherapy resistance in triple-negative cancer

The metabolism of cancer cells may play a key role in their ability to evade the immune system. This is demonstrated by a new study conducted by researchers at the University of Liège, which reveals how methylglyoxal stress – a by-product of tumor metabolism – promotes immunosuppression and the formation of metastases, and may contribute to resistance to immunotherapy and the progression of triple-negative cancer.

9 Sep 2026

New genetic map helps track aggressive prostate cancer development

Prostate cancer is the second most common form of cancer among men globally. Yet, we still know relatively little about why the disease develops or why some men live with it for years while in others it progresses aggressively.

9 Sep 2026

New genomic language AI model excels in predicting the pathogenicity of genetic variants

More than two decades after scientists first sequenced the entire human genome - all 3 billion "letters," or base pairs, of DNA code - the meaning of much of this code remains a mystery.

9 Sep 2026

Caloric restriction reduces genetic mutations across the mouse genome

Mutations are changes in the molecular "letters" that make up DNA, the genetic blueprint for cells. Mutations build up with age in every cell when DNA is damaged or when cells make mistakes in fixing or copying it.

9 Sep 2026

Study shows how the microbiome shapes lung cancer immunotherapy outcomes

Despite the revolutionary impact of immune checkpoint inhibitors on cancer therapy, 60% to 80% of patients with NSCLC still show suboptimal responses.

9 Sep 2026

New laser-fabricated plasmonic chip accurately identifies and sorts cancer cells

Novel laser-fabricated plasmonic chip combines 185 nm Raman resolution and deep learning to identify and sort cancer cells with 96.2% accuracy.

9 Sep 2026

New integrated framework advances precision surgery for liver cancer

Hepatocellular carcinoma is the sixth most common malignancy and the third leading cause of cancer-related death globally.

9 Sep 2026

New AI method tracks immune responses without known antibody databases

A research team comprising Associate Professor FUNAKOSHI Yohei, Associate Professor YAKUSHIJIN Kimikazu, Professor MINAMI Hironobu, and Associate Professor OHJI Goh of Kobe University, together with graduate student MASUDA Genki, then-graduate student IIZUMI Shunsuke, Associate Professor OHUE Masahito, and colleagues at the Institute of Science Tokyo, has developed a new analysis method, LM-QASAS.

9 Sep 2026

Is stroke risk higher after a cancer diagnosis?

New research indicates that people with invasive cancer face an elevated risk of experiencing a stroke, especially in the first few months after diagnosis and especially if they have certain types of cancer.

9 Sep 2026

AlphaGenome Atlas maps billions of genetic changes with AI

The human genome contains approximately 3 billion DNA letters, creating more than 9 billion possible single-letter changes.

9 Sep 2026

UCLA researchers develop scalable TCR therapy for solid tumors

T cell receptor, or TCR, therapy is a cancer treatment that genetically reprograms immune cells, called T cells, to hunt down cancer with precision. It's similar to another treatment, CAR T-cell therapy, but with one key difference: CAR T-cell therapy can only spot proteins that naturally appear outside of a cancer cell.

8 Sep 2026

New AI tool automates colonoscopy quality assessment at scale

Colonoscopies are one of the most effective ways to prevent colorectal cancer, which is surging among young adults in the U.S. Yet, the quality of each procedure can vary substantially from one physician to another.

8 Sep 2026